Clinical Trial Update: Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating cardiovascular effects of growth hormone therapy in adults with growth hormone deficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 4 | Status: TERMINATED